Spanish Red Biotech Pipeline

Roche

ALEGLITAZAR

Type: Biodrugs/ Drugs
Therapeutic area: Cardiovascular and circulatory systems
Metabolic / Endocrinology
Indication: Atherosclerosis
Phase: 3Phase III in Spain, 2Phase II, 1Phase I